Health e News
In a few week’s time, results of a major Phase 3 microbicide trial will be released and the women who took part can’t wait for the results
Big pharmaceutical companies need to change the way they work to reach 85% of the world’€™s consumers who don’€™t have proper access to medicine.
Madwaleni Hospital, in rural Mbashe just outside Mtata, in the Eastern Cape has come up with a new strategy to get more people to come for HIV testing. It takes testing services to the people.
Results from the first ever microbocide trial to go through all phases of research are due to be released early next year. A microbicide is a substance that can be inserted vaginally or anally with the aim of protecting its users from HIV infection.
As the international community is focusing on HIV/AIDS, malaria and tuberculosis another rapidly growing epidemic, diabetes, is also demanding attention.
Improved diagnostics, new medicines for drug resistant TB, the integration of HIV and TB treatment, increased funding and political will are some of the resources needed for a stronger effort against Tuberculosis.
The French humanitarian agency, Doctors Without Borders (MSF), has called for a new approach in dealing with patients with Multi-Drug Resistant Tuberculosis.
Activists have called for global action to stem the tide of deaths attributed to tuberculosis.
Clinic fails to test her for TB, Brooklyn refuses to admit her and doctor advises an abortion but Busi Beko and her daughter survive MDR TB.
Tuberculosis (TB) and its drug resistant strain is out of control in Zimbabwe, advocacy organisations in the country have warned.
The world is in desperate need of better medicines to deal both with the increase in multi-drug resistant TB and the problem of the co-infection of TB and HIV, say experts.
Health experts say the high level of tobacco use among South African children of school going age is worrisome.
